Xinhua Pharmaceutical (000756.SZ) subsidiary obtains drug registration certificate for donepezil hydrochloride orally disintegrating tablets

Zhito Finance APP News: Xinhua Pharmaceutical (000756.SZ) announced that recently, its wholly-owned subsidiary Shandong Zibo Xinda Pharmaceutical Co., Ltd. (hereinafter referred to as "Xinda Pharmaceutical") received the "Drug Registration Certificate" for Donepezil Hydrochloride Orally Disintegrating Tablets (hereinafter referred to as "this product") approved and issued by the National Medical Products Administration. This product is used for the treatment of symptoms of mild, moderate, or severe Alzheimer's disease.